Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07397325
PHASE1/PHASE2

Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia

Sponsor: Applied Biology, Inc.

View on ClinicalTrials.gov

Summary

Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia

Key Details

Gender

FEMALE

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-04-16

Completion Date

2026-12-07

Last Updated

2026-04-09

Healthy Volunteers

No

Interventions

DRUG

DA-020

7mL application of DA-020 (Topical Oxymetazoline)

DRUG

Placebo

Topical placebo solution

DRUG

DA-020 and Hyperforin

7mL application of DA-020 (Topical Oxymetazoline) and Hyperforin (1.5%)

Locations (2)

Hospital Samel

Manaus, Brazil

University of Rome ("G. Marconi")

Rome, Italy